News Report

————————————————————————————————————————————————————

————————————————————————————————————————————————————

15

/ Jan 2026

Santo Therapeutics and Yanyin Technology have reached a strategic cooperation to jointly build the virtual cell platform

——————

Read More →

————————————————————————————————————————————————————

22

/ Dec 2025

Conference Briefing | Breakthrough in Precision Treatment of Neurofibroma, Gene Therapy Enters Clinical Trial Phase

——————

Read More →

————————————————————————————————————————————————————

28

/ Oct 2025

Dr. Zhou Lu, CEO of Santo Therapeutics, attended the 3rd US-China IRI Oncology Clinical Academic Annual Conference | Subforum on Research Advances in Neurofibromatosis

——————

Read More →

————————————————————————————————————————————————————

28

/ Sep 2025

Santo Therapeutics has completed tens of millions in angel plus round financing to accelerate the progress of its lentivirus gene therapy pipeline

——————

Read More →

————————————————————————————————————————————————————

15

/ Sep 2025

Santo Therapeutics has been awarded the honor of "2025 CSGCT Rising Star – Star of CGT"

——————

Read More →

————————————————————————————————————————————————————

<

1

>